165 related articles for article (PubMed ID: 18798110)
1. Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma.
Liu X; Hong XN; Gu YJ; Wang BY; Luo ZG; Cao J
Leuk Lymphoma; 2008 Sep; 49(9):1778-83. PubMed ID: 18798110
[TBL] [Abstract][Full Text] [Related]
2. Fatal interstitial pneumonitis related to rituximab-containing regimen.
Herishanu Y; Polliack A; Leider-Trejo L; Grieff Y; Metser U; Naparstek E
Clin Lymphoma Myeloma; 2006 Mar; 6(5):407-9. PubMed ID: 16640819
[TBL] [Abstract][Full Text] [Related]
3. Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab.
Zhou T; Shen Q; Peng H; Chao T; Zhang L; Huang L; Yang K; Thapa S; Yu S; Jiang Y
Ann Hematol; 2018 Jan; 97(1):141-147. PubMed ID: 29086009
[TBL] [Abstract][Full Text] [Related]
4. [Interstitial pneumonitis as a side effect of rituximab].
Kemming JL; van Zeeland RE; Ullmann EF; Mattijssen EJ
Ned Tijdschr Geneeskd; 2009; 153():A526. PubMed ID: 19785875
[TBL] [Abstract][Full Text] [Related]
5. [Alveolar hypoxemic interstitial pneumonia related to rituximab therapy].
Jullien V; Perrin C; Peyrade F; Lemoigne F; Chichmanian RM; Blaive B
Rev Mal Respir; 2004 Apr; 21(2 Pt 1):407-10. PubMed ID: 15211254
[TBL] [Abstract][Full Text] [Related]
6. [18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy.
Kalkanis D; Stefanovic A; Paes F; Escalon MP; Serafini A; Lossos IS
Leuk Lymphoma; 2009 Jun; 50(6):904-11. PubMed ID: 19455459
[TBL] [Abstract][Full Text] [Related]
7. Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma.
Katsuya H; Suzumiya J; Sasaki H; Ishitsuka K; Shibata T; Takamatsu Y; Tamura K
Leuk Lymphoma; 2009 Nov; 50(11):1818-23. PubMed ID: 19863173
[TBL] [Abstract][Full Text] [Related]
8. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of rituximab-induced interstitial lung disease].
Huang C; Lu ZW; Yang YQ; Chen H; Huang DP; He HS
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Oct; 40(10):730-735. PubMed ID: 29050126
[No Abstract] [Full Text] [Related]
10. Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab.
Salmasi G; Li M; Sivabalasundaram V; Panzarella T; Tsang R; Kukreti V; Crump M; Kuruvilla J
Leuk Lymphoma; 2015 Jun; 56(6):1659-64. PubMed ID: 25356925
[TBL] [Abstract][Full Text] [Related]
11. Two cases of interstitial pneumonitis caused by rituximab therapy.
Lee Y; Kyung SY; Choi SJ; Bang SM; Jeong SH; Shin DB; Lee JH
Korean J Intern Med; 2006 Sep; 21(3):183-6. PubMed ID: 17017668
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous intravascular large B-cell lymphoma treated with combination chemotherapy and complicated by rituximab-induced interstitial lung disease.
Park GH; Kim CH; Chung WK; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
Acta Derm Venereol; 2010 May; 90(3):296-8. PubMed ID: 20526551
[No Abstract] [Full Text] [Related]
13. Rituximab-induced subacute interstitial pneumonitis: a case report and review of literature.
Subramanian M; Manjunath R; Kilara N; Mohan Rao KN
J Cancer Res Ther; 2010; 6(3):344-6. PubMed ID: 21119272
[TBL] [Abstract][Full Text] [Related]
14. [Rituximab-induced interstitial lung disease].
Fernández Casares M; Espósito G; González A; Segovia J; Galperín Mde L; Del Valle E
Medicina (B Aires); 2013; 73(4):343-5. PubMed ID: 23924535
[TBL] [Abstract][Full Text] [Related]
15. Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphoma.
Alexandrescu DT; Dutcher JP; O'Boyle K; Albulak M; Oiseth S; Wiernik PH
Leuk Lymphoma; 2004 Nov; 45(11):2321-5. PubMed ID: 15512824
[TBL] [Abstract][Full Text] [Related]
16. Rituximab-induced fatal interstitial pneumonitis: case report.
Vulsteke C; Dierickx D; Verbeken E; Wolter P; Thomas J; Schöffski P
Leuk Lymphoma; 2010 Mar; 51(3):546-8. PubMed ID: 20038238
[No Abstract] [Full Text] [Related]
17. Rituximab-induced interstitial lung disease.
Wagner SA; Mehta AC; Laber DA
Am J Hematol; 2007 Oct; 82(10):916-9. PubMed ID: 17597477
[TBL] [Abstract][Full Text] [Related]
18. Severe interstitial pneumonitis following rituximab and bleomycin-containing combination chemotherapy.
Ghesquieres H
Ann Oncol; 2005 Aug; 16(8):1399. PubMed ID: 15857843
[No Abstract] [Full Text] [Related]
19. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
20. Interstitial pneumonia after autologous hematopoietic stem cell transplantation in B-cell non-hodgkin lymphoma.
Kato H; Yamamoto K; Taji H; Oki Y; Chihara D; Seto M; Kagami Y; Morishima Y
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):483-9. PubMed ID: 21978956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
